Abstract
The purpose of the present investigation was to explore the effect of cyclodextrin (CD) as permeation enhancer through rat skin in the form of a valuable and stable transdermal drug delivery system by exploiting its favorable properties. Phase-solubility studies demonstrated that the CD:drug ratio 1:2 was employed in complexation. Solid-state characterizations of complexes was performed by differential scanning calorimetry, X-ray diffractometry, Fourier transform infrared, nuclear magnetic resonance spectrophotometry analysis, and scanning electron micrograph. The HP-β-CD by virtue of its greater stability than the pure curcumin (CMN), allowed greater transdermal flux of CMN indicative of enhanced permeation via CMN-2-hydroxy propyl β cyclodextrins (HP-β-CD). Permeability studies of drug, complex, and with various penetration enhancers (PEs), were performed through rat skin, highlighted a favorable effect of CDs on drug permeation rate, due to its solubilizing action; in contrast with unpredictably poor skin permeation of pure drug. The complexes were found to cause relatively less irritation as compared to the pure drug and drug with PEs in skin irritation studies. The anti-inflammatory activity using paw odema model showed th...Continue Reading
References
Aug 1, 1976·Biochemical Pharmacology·O P Sharma
Feb 1, 1992·The Journal of Pharmacy and Pharmacology·K UekamaK Noda
Nov 1, 1996·Journal of Pharmaceutical Sciences·R A Rajewski, V J Stella
Apr 1, 1997·The Journal of Pharmacy and Pharmacology·M V BentleyJ H Collett
Apr 21, 1998·Journal of Pharmaceutical Sciences·S TenjarlaT Mandal
Jun 14, 2000·International Journal of Pharmaceutics·R F LopezM V Bentley
Apr 24, 2001·Skin Pharmacology and Applied Skin Physiology·A DoliwaP Ygartua
Aug 8, 2001·International Journal of Pharmaceutics·T Loftsson, M Masson
Mar 7, 2002·Journal of Agricultural and Food Chemistry·Ben-Li ZhangMaryvonne L Martin
Jun 13, 2002·Journal of Agricultural and Food Chemistry·Guddadarangavvanahally K JayaprakashaKunnumpurath K Sakariah
Nov 29, 2002·Drug Development and Industrial Pharmacy·Linda A FeltonDonald A Godwin
Sep 5, 2003·International Journal of Pharmaceutics·M M R DiasJ Hadgraft
Jan 20, 2004·AAPS PharmSciTech·G KrishnaB Almassian
May 8, 2004·International Journal of Pharmaceutics·R J Babu, J K Pandit
Feb 14, 2006·International Journal of Pharmaceutics·Francesca MaestrelliPaola Mura
Sep 22, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vaibhav DubeyN K Jain
Jan 30, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jing YangLinda A Felton
Aug 5, 2008·International Journal of Pharmaceutics·Branko J DrakulićMire Zloh
Dec 9, 2008·Journal of Pharmaceutical and Biomedical Analysis·Ali H Al-MarzouqiAbdu Adem
Jan 23, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Wei YangRobert O Williams
Feb 6, 2010·Journal of Pharmaceutical Sciences·Steven W BaertschiHanne H Tønnesen
May 4, 2010·International Journal of Pharmaceutics·Victoria KlangClaudia Valenta
Nov 9, 2010·International Journal of Pharmaceutics·Francesca UngaroMaria Immacolata La Rotonda
Citations
Mar 20, 2014·Journal of Microencapsulation·Y S TuZ Q Shi
Jul 29, 2017·Advanced Materials·Rong YangDaniel S Kohane
Sep 7, 2018·Drug Development Research·Shery Jacob, Anroop B Nair
Jan 31, 2020·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Duong T T PhamThao T D Tran
Mar 12, 2021·Journal of Biomaterials Science. Polymer Edition·Ashish Kumar GargPrashant Kesharwani
Jul 23, 2021·Journal of Pharmaceutical Sciences·Shivansh SrivastavaPrashant Kesharwani
Sep 10, 2021·International Journal of Pharmaceutics·Suman GyanewaliSushama Talegaonkar